logo opgs

Available Treatments of nerve gas poisoning

Treating organophosphorus poisoning involves a combination of supportive care and specific antidotes. Early recognition and prompt treatment are critical for improving outcomes in cases of organophosphorus poisoning. Treatment of this condition remains a significant medical challenge.

  1. Decontamination:
    • Remove the Source: Ensure that the patient is removed from exposure (e.g., clothing removal, skin washing).
    • Gastrointestinal Decontamination: Activated charcoal may be administered if ingestion occurred within a few hours.
  2. Atropine:
    • Mechanism: Atropine is an anticholinergic agent that blocks the effects of excess acetylcholine at muscarinic receptors.
    • Administration: Given intravenously or intramuscularly, with doses adjusted based on clinical response (e.g., to manage respiratory secretions and bradycardia).
helping people
  1. Pralidoxime (2-PAM):
    • Mechanism: Pralidoxime can reactivate acetylcholinesterase by breaking the bond formed between the organophosphate and the enzyme, but it is only effective if given early. Its activity has been repeatedly challenged:
      1. “Pralidoxime in organophosphate poisoning : 60 years if hope and despair” (Worek, Bundeswehr, 2016).
      2. “Pralidoxime is No longer fir for Purpose as an Antidote to Organophosphorus poisoning in the United Kingdom” (Corby, 2024, Disaster Medicine and Public Health Preparedness).
    • Administration: Can be administered intravenously or intramuscularly, often in conjunction with atropine.
  2. Supportive Care
  3. Benzodiazepines
  4. Additional Therapies:
    • Fluid Resuscitation: To maintain blood pressure and hydration.
    • Management of Complications: Treatment of secondary infections or other complications that may arise.

In few words, we can say that current treatments have significant limitations :

☞ Must be administered promptly
☞ Limited activity
☞ Limited stability
☞ Narrow spectrum
☞ Do not cross the blood-brain barrier
☞ No activity against aged AChE

A study published by Cambridge University Press shows that current treatments, such as pralidoxime, are no longer fit for purpose as an antidote to organophosphate poisoning.

You can consult it at the following address:
https://www.cambridge.org/core/journals/disaster-medicine-and-public-health-preparedness/article/pralidoxime-is-no-longer-fit-for-purpose-as-an-antidote-to-organophosphate-poisoning-in-the-united-kingdom/8421AF115463EBD96D000B33EA24DE08